On the Record · Eli Lilly
Eli Lilly subsidiaries, as it lists them
The subsidiaries Eli Lilly lists in its latest annual report, with the jurisdiction of each, linked to the filing.
Subsidiaries it lists
| Subsidiary | Jurisdiction |
|---|---|
| Adverum Biotechnologies, Inc. | Delaware |
| Adverum NC, LLC | Delaware |
| Akouos, Inc. | Delaware |
| Alnara Pharmaceuticals, Inc. | Delaware |
| Annapurna Therapeutics, Ltd. | Ireland |
| Aparito Espanya S.L. | Spain |
| Aparito Limited | United Kingdom |
| Aparito LLC | Delaware |
| ARMO Biosciences, Inc. | Delaware |
| Avalanche Australia Pty Ltd. | Australia |
| Avid Radiopharmaceuticals, Inc. | Delaware |
| CoLucid Pharmaceuticals, Inc. | Delaware |
| Compania Farmaceutica Eli Lilly de Centro America S.A. | Guatemala |
| CPD 4, Inc. | Delaware |
| Dermira, Inc. | Delaware |
| DICE Alpha Inc. | Delaware |
| DICE Molecules SV, Inc. | Delaware |
| DICE Therapeutics, Inc. | Delaware |
| Disarm Therapeutics Inc. | Delaware |
| Dista Ilac Ticaret Limited Sirketi | Turkey |
| Dista, S.A. | Spain |
| Dista-Produtos Quimicos & Farmaceuticos, LDA | Portugal |
| ELC EHS, LLC | Indiana |
| ELCO Dominicana S.R.L. | Dominican Republic |
| ELCO for Trading and Marketing, S.A.E. | Egypt |
| ELCO Insurance Company Limited | Bermuda |
| ELCO Management, Inc. | Delaware |
| ELGO Insurance Company Limited | Bermuda |
| Eli Lilly (Malaysia) Sdn. Bhd. | Malaysia |
| Eli Lilly (Philippines), Incorporated | Philippines |
| Eli Lilly (S.A.) (Proprietary) Limited | South Africa |
| Eli Lilly (Singapore) Pte. Ltd. | Singapore |
| Eli Lilly (Suisse) S.A. | Switzerland |
| Eli Lilly and Company (India) Pvt. Ltd. | India |
| Eli Lilly and Company (Ireland) Limited | Ireland |
| Eli Lilly and Company (N.Z.) Limited | New Zealand |
| Eli Lilly and Company (Taiwan), Inc. | Taiwan |
| Eli Lilly and Company Limited | United Kingdom |
| Eli Lilly Asia Pacific SSC Sdn Bhd | Malaysia |
| Eli Lilly Asia, Inc. | Delaware |
| Eli Lilly Australia Pty. Limited | Australia |
| Eli Lilly Benelux S.A. | Belgium |
| Eli Lilly B-H d.o.o. | Bosnia |
| Eli Lilly Bienes y Servicios S. de R.L. de C.V. | Mexico |
| Eli Lilly Canada Inc. | Canada |
| Eli Lilly Clinical Diagnostics Laboratory LLC | Indiana |
| Eli Lilly Cork Limited | Ireland |
| Eli Lilly CR s.r.o. | Czech Republic |
| Eli Lilly Danmark A/S | Denmark |
| Eli Lilly de Costa Rica, S.R.L. | Costa Rica |
| Eli Lilly do Brasil Limitada | Brazil |
| Eli Lilly Drug Store LLC | United Arab Emirates |
| Eli Lilly Egypt for Trading Company S.A.E. | Egypt |
| Eli Lilly European Clinical Trial Services S.A. | Belgium |
| Eli Lilly Export S.A. | Switzerland |
| Eli Lilly farmacevtska druzba, d.o.o. | Slovenia |
| Eli Lilly Finance, S.A. | Switzerland |
| Eli Lilly Ges.m.b.H. | Austria |
| Eli Lilly Group Limited | United Kingdom |
| Eli Lilly Hrvatska d.o.o. | Croatia |
| Eli Lilly Interamerica Inc., y Compania Limitada | Chile |
| Eli Lilly Interamerica, Inc. | Indiana |
| Eli Lilly International Corporation | Indiana |
| Eli Lilly Ireland Holdings Limited | Ireland |
| Eli Lilly Israel Ltd. | Israel |
| Eli Lilly Italia S.p.A. | Italy |
| Eli Lilly Japan K.K. | Japan |
| Eli Lilly Kinsale Limited | Ireland |
| Eli Lilly Nederland B.V. | Netherlands |
| Eli Lilly Norge A.S. | Norway |
| Eli Lilly Pakistan (Pvt.) Ltd. | Pakistan |
| Eli Lilly Polska Sp. z.o.o. (Ltd.) | Poland |
| Eli Lilly Regional Operations GmbH | Austria |
| Eli Lilly Romania S.R.L. | Romania |
| Eli Lilly S.A. | Switzerland |
| Eli Lilly Saudi Arabia Limited | Saudi Arabia |
| Eli Lilly Services India Private Limited | India |
| Eli Lilly Services Peru S.A.C | Peru |
| Eli Lilly Slovakia s.r.o. | Slovakia |
| Eli Lilly Sweden AB | Sweden |
| Eli Lilly Vostok S.A. | Switzerland |
| Eli Lilly y Compania de Mexico, S.A. de C.V. | Mexico |
| Eli Lilly y Compania de Venezuela, S.A. | Venezuela |
| Emergence Therapeutics France SAS | France |
| Glycostasis, Inc. | Delaware |
| Greenfield-Produtos Farmaceuticos, Lda. | Portugal |
| ICOS Corporation | Washington |
| ImClone LLC | Delaware |
| ImClone Systems Holdings, Inc. | Delaware |
| Irisfarma S.A. | Spain |
| Isopro Holdings LLC | Delaware |
| LDH I Corporation | Delaware |
| LDH II Corporation | Delaware |
| LDH III Corporation | Delaware |
| LDH IV Corporation | Delaware |
| LDH V 2023 Corporation | Delaware |
| LDH VI Corporation | Delaware |
| LDH VII Corporation | Delaware |
| LDH VIII Corporation | Delaware |
| Lilly (Beijing) Medical Tech Innovation Co., Ltd. | China |
| Lilly (Shanghai) Management Co., Ltd. | China |
| Lilly Asia Ventures Fund I, L.P. | Cayman Islands |
| Lilly Asia Ventures Fund II, L.P. | Cayman Islands |
| Lilly Asian Ventures Fund III, L.P. | Cayman Islands |
| Lilly Cayman Holdings | Cayman Islands |
| Lilly Centre for Clinical Pharmacology PTE. LTD. | Singapore |
| Lilly China Research and Development Co., Ltd | China |
| Lilly del Caribe, Inc. | Cayman Islands |
| Lilly Deutschland GmbH | Germany |
| Lilly France S.A.S. | France |
| Lilly Global Nederland Holdings B.V. | Netherlands |
| Lilly Global Services, Inc. | Indiana |
| Lilly Holding GmbH | Germany |
| Lilly Holdings B.V. | Netherlands |
| Lilly Hungaria KFT | Hungary |
| Lilly Ilac Ticaret Limited Sirketi | Turkey |
| Lilly Japan Financing G.K. | Japan |
| Lilly Korea Ltd. | Korea |
| Lilly Lebanon Advanced Therapies LLC | Indiana |
| Lilly Nederland Finance B.V. | Netherlands |
| Lilly Nederland Holding B.V. | Netherlands |
| Lilly Pharma Ltd. | Russia |
| Lilly Portugal - Produtos Farmaceuticos, Lda. | Portugal |
| Lilly S.A. | Spain |
| Lilly Suzhou Pharmaceutical Co. Ltd. | China |
| Lilly Trading Co. LTD | China |
| Lilly USA, LLC | Indiana |
| Lilly Ventures Fund I LLC | Delaware |
| LillyDirect Pharmacy, LLC | Delaware |
| Loxo Oncology, Inc. | Delaware |
| Mablink Bioscience S.A.S. | France |
| Manet Holdings LLC | Delaware |
| Morphic Holding, Inc. | Delaware |
| Morphic Therapeutic UK Ltd. | United Kingdom |
| Morphic Therapeutic, Inc. | Delaware |
| NexPharm Parent Holdco, LLC | Delaware |
| OY Eli Lilly Finland AB | Finland |
| Pandinus MSC, Inc. | Massachusetts |
| Petra Pharma Corporation | Delaware |
| Pharmaserve-Lilly S.A.C.I. | Greece |
| Point Biopharma Corp. | Canada |
| Point Biopharma Global Inc. | Delaware |
| Point Biopharma Inc. | Delaware |
| Point Biopharma USA Inc. | Delaware |
| Prevail Therapeutics Inc. | Delaware |
| Protomer Technologies, Inc. | Delaware |
| Scorpion Therapeutics, Inc. | Delaware |
| SGX Pharmaceuticals, Inc. | Delaware |
| Sigilon Therapeutics Inc. | Delaware |
| SiteOne Therapeutics, Inc. | Delaware |
The list is long; these are the first 150 as the company lists them. From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.
Read from Eli Lilly’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-12. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.